GREY:IMVIF - Post by User
Comment by
Hideawayon Jun 01, 2019 3:13pm
119 Views
Post# 29791446
RE:RE:News release - thoughts please?
RE:RE:News release - thoughts please?Considering that they were treating patients that had little hope for stability or cure prior to dpx, I thought the results were in line with expectations for the small number (7) in the monotherapy cohort. Of the seven evaluable 5 or 71% showed a robust response, whereas only 2 progressed.Of the 4 with low tumor burden, 3 had demonstrated SD with two reductions in tumor size.
I am not knowledgeable enought to draw conclusive results, but ,at first glance, the results were about what I expected at this early stage.
There may have some over-expectation for these initial findings and ,if so, I would agree with europe that Monday may not be that great for IMV. The data was not presented as clearly as I would have desired but it did not appear over-stated.
Looking forward to more comments and perhaps tomorrows call will provide additional clarity.
GLTA